Tag Archives: Novartis

Cerulean Pharma Inc (NASDAQ:CERU) is running up towards the end of the week on suggestions that the company could be fielding buy out offers, or at least pitching for the sale of some of its lead development assets. The company closed out on...

ImmunoGen, Inc. (NASDAQ:IMGN) put out its latest earnings last week, and markets were pretty much flat on the news. That’s a correct response in our opinion – these numbers mean very little for a company at the stage in which Immunogen...

Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes. Here is another one. The company is GenVec Inc (NASDAQ:GNVC), and...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter